PARTNER 3

A study designed to establish the safety and effectiveness of the SAPIEN 3 Transcatheter Heart Valve (THV) in low-risk patients requiring aortic valve replacement who have severe, calcific, symptomatic aortic stenosis.

Type: Device trial

Principal Investigator: Sergio Waxman, MD

Trial is open for enrollment

• Newark Beth Israel Medical Center